Monnier VM - Search Results

1

Monocyte/macrophage response to beta 2-microglobulin modified with advanced glycation end products.

Miyata T, Iida Y, Ueda Y, Shinzato T, Seo H, Monnier VM, Maeda K, Wada Y. Miyata T, et al. Among authors: monnier vm. Kidney Int. 1996 Feb;49(2):538-50. doi: 10.1038/ki.1996.77. Kidney Int. 1996. PMID: 8821842 Free article.

2

Identification of pentosidine as a native structure for advanced glycation end products in beta-2-microglobulin-containing amyloid fibrils in patients with dialysis-related amyloidosis.

Miyata T, Taneda S, Kawai R, Ueda Y, Horiuchi S, Hara M, Maeda K, Monnier VM. Miyata T, et al. Among authors: monnier vm. Proc Natl Acad Sci U S A. 1996 Mar 19;93(6):2353-8. doi: 10.1073/pnas.93.6.2353. Proc Natl Acad Sci U S A. 1996. PMID: 8637877 Free PMC article.

3

Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy.

Horie K, Miyata T, Maeda K, Miyata S, Sugiyama S, Sakai H, van Ypersole de Strihou C, Monnier VM, Witztum JL, Kurokawa K. Horie K, et al. Among authors: monnier vm. J Clin Invest. 1997 Dec 15;100(12):2995-3004. doi: 10.1172/JCI119853. J Clin Invest. 1997. PMID: 9399945 Free PMC article.

4

Mechanisms for the formation of glycoxidation products in end-stage renal disease.

Weiss MF, Erhard P, Kader-Attia FA, Wu YC, Deoreo PB, Araki A, Glomb MA, Monnier VM. Weiss MF, et al. Among authors: monnier vm. Kidney Int. 2000 Jun;57(6):2571-85. doi: 10.1046/j.1523-1755.2000.00117.x. Kidney Int. 2000. PMID: 10844627 Free article.

5

Early and advanced glycosylation end products. Kinetics of formation and clearance in peritoneal dialysis.

Friedlander MA, Wu YC, Elgawish A, Monnier VM. Friedlander MA, et al. Among authors: monnier vm. J Clin Invest. 1996 Feb 1;97(3):728-35. doi: 10.1172/JCI118471. J Clin Invest. 1996. PMID: 8609229 Free PMC article.

6

Amyloidosis, advanced glycation end products and Alzheimer disease.

Smith MA, Monnier VM, Sayre LM, Perry G. Smith MA, et al. Among authors: monnier vm. Neuroreport. 1995 Aug 21;6(12):1595-6. doi: 10.1097/00001756-199508000-00001. Neuroreport. 1995. PMID: 8527721 No abstract available.

7

Advanced glycation in diabetes, aging and age-related diseases: conclusions.

Monnier VM, Taniguchi N. Monnier VM, et al. Glycoconj J. 2016 Aug;33(4):691-2. doi: 10.1007/s10719-016-9711-1. Glycoconj J. 2016. PMID: 27421862 No abstract available.

8

Pharmacological modulation of AGEs: a unique role for redox-active metal ions.

Weiss MF, Saxena AK, Monnier VM. Weiss MF, et al. Among authors: monnier vm. Perit Dial Int. 1999;19 Suppl 2:S62-7. Perit Dial Int. 1999. PMID: 10406496 No abstract available.

9

Glucosepane: a poorly understood advanced glycation end product of growing importance for diabetes and its complications.

Monnier VM, Sun W, Sell DR, Fan X, Nemet I, Genuth S. Monnier VM, et al. Clin Chem Lab Med. 2014 Jan 1;52(1):21-32. doi: 10.1515/cclm-2013-0174. Clin Chem Lab Med. 2014. PMID: 23787467 Free PMC article. Review.

10

Age-related increase in an advanced glycation end product in penile tissue.

Jiaan DB, Seftel AD, Fogarty J, Hampel N, Cruz W, Pomerantz J, Zuik M, Monnier VM. Jiaan DB, et al. Among authors: monnier vm. World J Urol. 1995;13(6):369-75. doi: 10.1007/BF00191219. World J Urol. 1995. PMID: 9116757

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

205 results

Search Page

Filters